CANY
SYRS

Caxton Associates (New York)’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Caxton Associates (New York)’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-6,683
Closed -$218K – 719
2021
Q4 		$218K Buy
+6,683
New +$218K 0.02% 454